Jul 16, 2026 09:01AM
Jul 16, 2026 09:00AM
Jun 25, 2026 09:03AM
Jun 25, 2026 09:00AM
Jun 5, 2026 02:35AM
Jun 1, 2026 02:53AM
May 31, 2026 08:00AM GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annua
May 30, 2026 08:00AM
May 5, 2026 04:01PM
Apr 21, 2026 04:54PM
Apr 21, 2026 04:53PM
Apr 10, 2026 05:39AM
Apr 10, 2026 04:00AM
Apr 7, 2026 04:01PM GRAIL integrates Galleri test into Epic health record platform
Apr 7, 2026 04:01PM
Apr 1, 2026 01:10PM
Apr 1, 2026 01:09PM
Mar 23, 2026 06:41AM
Mar 18, 2026 06:00AM
Feb 20, 2026 09:18AM
Feb 20, 2026 07:57AM GRAIL, Inc. (GRAL) PT Lowered to $80 at Canaccord Genuity
Feb 19, 2026 04:02PM
Feb 19, 2026 04:02PM
Feb 19, 2026 04:01PM
Feb 19, 2026 05:42AM
Feb 17, 2026 03:35AM
Jan 29, 2026 07:25PM
Jan 26, 2026 06:25AM Canaccord Genuity Reiterates Buy Rating on GRAIL, Inc. (GRAL)
Jan 14, 2026 06:34AM
Jan 13, 2026 06:25AM
Nov 12, 2025 04:02PM
Oct 22, 2025 06:23AM
Oct 20, 2025 06:01AM
Oct 20, 2025 06:00AM
Oct 17, 2025 06:08PM GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings
Oct 17, 2025 06:08PM
Oct 16, 2025 08:23AM
Oct 16, 2025 08:22AM
Sep 23, 2025 09:04AM
Sep 23, 2025 09:01AM
Aug 12, 2025 04:02PM
Jun 18, 2025 09:01AM GRAIL, Inc. (GRAL) Announces Positive Top-Line Results From The Galleri PATHFINDER 2 Registrational Study
Jun 18, 2025 09:01AM
May 14, 2025 04:32AM
May 13, 2025 04:01PM
May 12, 2025 04:01PM
May 12, 2025 04:01PM
Apr 22, 2025 04:01PM
Apr 21, 2025 06:22AM Canaccord Genuity Starts GRAIL, Inc. (GRAL) at Buy
Feb 20, 2025 04:02PM

326,431 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All